Records containing: SARS-CoV-2
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-08A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity in Relation to the Product Attributes of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Adults ≥50 to <65 Years of Age
-
CLINICAL_TRIALS study record update · 2026-04-24Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)
-
CLINICAL_TRIALS study record update · 2026-04-23A Prospective, Single-arm, Open-label, Non-interventional, Multicenter to Assess the Safety of BNT162b2 in Domestic Post-marketing Surveillance
-
CLINICAL_TRIALS study record update · 2026-04-16A Multi-centre, Prospective, Observational Post-marketing Surveillance to Investigate the Long-term Safety of SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE Under Routine Clinical Care in Korea
-
CLINICAL_TRIALS study record update · 2026-03-27Study of the Immunological and Virological Response of Patients Infected With SARS-CoV-2 and Presenting an Asymptomatic or Pauci-symptomatic Form
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase 3b/4, Open-label Study to Assess the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
-
CLINICAL_TRIALS study record update · 2026-03-20Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population: A Phase II, Randomized, Placebo-controlled, Observer-blinded Study
-
CLINICAL_TRIALS study record update · 2026-03-18Clinical Performance Evaluation of the VitaSIRO Solo™ SARS-CoV-2/Flu/RSV Assay
-
CLINICAL_TRIALS study record update · 2026-03-13Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
-
CLINICAL_TRIALS study record update · 2026-03-12Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Modified mRNA Vaccines Using a Systems Biology Approach in Healthy Adults
-
CLINICAL_TRIALS study record update · 2026-03-12A Phase 4, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of mRNA-1283 And mRNA-1273 Variant-Containing Formulation in Adults 50 to 64 Years of Age Without Underlying Conditions That Put Them at High Risk for Severe Outcomes From COVID-19
-
CLINICAL_TRIALS study record update · 2026-02-13Master Protocol for Early Treatment and Post-Exposure Prophylaxis of COVID-19 Adaptive Platform Trial PROTECT-APT 1
-
CLINICAL_TRIALS study record update · 2026-02-04Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region Study to Quantify the Presence of Antibodies and Cellular Immunity Against SARS-CoV-2 in the Population of Persons Participating in the SARS-CoV-2-CZ-PREVAL Study in 2020
-
CLINICAL_TRIALS study record update · 2026-02-02IPrognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2
-
CLINICAL_TRIALS study record update · 2026-01-12Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
-
CLINICAL_TRIALS study record update · 2026-01-07The Impact of the COVID-19 Pandemic on the Patient in Need of an Intervention - COVID Surg III
-
CLINICAL_TRIALS study record update · 2026-01-06A Randomized Controlled Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
-
CLINICAL_TRIALS study record update · 2025-12-30Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection According to the Clinical Severity of the Infection.
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 1/2, Randomized, Observer-blind, Active-Control Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-based Influenza and SARS-CoV-2 Multi-component Vaccines in Healthy Adults
-
CLINICAL_TRIALS study record update · 2025-12-18SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following COVID-19 Vaccination Using an Adenoviral Vector
-
CLINICAL_TRIALS study record update · 2025-12-10Immunological Profiling of Patients With COVID-19 in Respiratory Distress
-
CLINICAL_TRIALS study record update · 2025-11-28A Phase 3, Randomized, Observer-Blind, Placebo- Controlled Cross-over Study to Evaluate the Efficacy, Safety, and Immunogenicity of S-268019 for the Prevention of COVID-19
-
CLINICAL_TRIALS study record update · 2025-11-26An Open-Label, Phase 3 Study to Evaluate the Safety and Immunogenicity of mRNA Vaccines for SARS-CoV-2 Variants in Participants Aged 6 Months to < 6 Years
-
CLINICAL_TRIALS study record update · 2025-11-26A Phase 2, Two-Part Study (Open-Label [Part 1] Followed by Observer-Blind/Randomized [Part 2]) to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 Vaccine in Participants Aged 12 Weeks to < 6 Months
-
CLINICAL_TRIALS study record update · 2025-11-20Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers